Midlands Extracellular Vesicles Network

Extracellular vesicles

Mission: Midlands Extracellular Vesicles Network (MEVN) is a joint partnership across the 7 Midlands Innovation Health institutions which aims to:

  1. Develop a vibrant multidisciplinary research community, bringing focus to the diverse Extracellular Vesicle (EV) research activity in the Midlands both academic and industrial.
  2. Facilitate inter-disciplinary and inter-sectoral research collaborations, to develop the next generation of EV based research programmes.
  3. Share best practice and provide a platform for collaborative rather than competitive bids, strengthening submissions to research councils for funding.
  4. Train, support and inspire the next generation of outstanding leaders in EV research.

Collaboration: The partnership structure comprises a senior and early career researcher from each institution:

   Aston University: Professor Andrew Devitt
   University of Birmingham: Dr Joshua Price
   Keele University: Dr Oksana Kehoe and Dr Nicholas Wragg
   University of Leicester: Professor Galina Mukamolova
   Loughborough University: Dr Owen Davies and Dr Soraya Williams
   University of Nottingham: Professor Lucy Fairclough (CHAIR) and Dr Hannah Jackson
   University of Warwick: Professor Dimitris Grammatopoulos and Dr Darius Koester

Support colleagues: Alex Archibald (MI Health), Ellen McGhee (MI) and Matt Vassey (Aston University).

Events: On 21st September 2023, MEVN held an inaugural (half day) virtual conference focussed on ‘Health and Inflammation’. This provided an opportunity for presentations, discussions, and conversations around this exciting and growing area of EV research. To watch recordings from this event click here.

MEVN is looking to run a series of virtual and in-person events. We anticipate these meetings will evolve in content, theme and location as the network grows and would love to engage the community around this as we move forwards. If you are interested in being involved, please get in touch.

Midlands Strengths and Capabilities Catalogue 
Biology
Biogenesis and secretion Nottingham
Cell death Aston
Communication and signalling (intercellular and extracellular) Aston, Nottingham
Complex biofluids Birmingham
Endothelial cells Aston
Epithelial cells Nottingham
Genome stability Aston
Immune-modulation Aston
Immune cells Nottingham
Lipidomics Aston
Membranes – biophysics and models Aston
Metabolomics Aston
Molecular biology Nottingham
Platelet-derived microvesicles Aston
Proteomics Aston, Birmingham, Nottingham
Redox biology Aston
RNA Birmingham, Nottingham
Stem cells Aston, Keele, Nottingham
Synthetic and semi-synthetic EVs Aston
T cells Keele
Trypanosomes genetics Warwick
Applications
Ageing Aston
Bioinformatics Birmingham
Biomarkers Aston
Cardiovascular disease Aston
Cancer and cancer therapies Aston, Birmingham, Nottingham
Dermatology Loughborough
Disease pathophysiology, prognosis, and outcomes Aston, Birmingham
Drug discovery Aston
DNA damage responses Aston
Exercise and metabolism Birmingham
Hypoxia/normoxia effects Keele
Inflammation, allergy and allergic sensitisation Aston, Keele, Nottingham, Warwick
Lung disease, respiratory infections, COPD, cystic fibrosis and IPF Keele, Nottingham
Maternity Warwick
Musculoskeletal Birmingham, Keele, Loughborough
Nanotechnology Aston
Neurology Aston, Nottingham
Regenerative Medicine Aston, Keele
Therapeutics Loughborough
Wound healing Aston, Keele
Virology Keele

Back

Share

Related Content

Other Regional Collaborations and Networks
Other Regional Collaborations and Networks

A unique academic team that truly integrates knowledge, expertise and resources across four leading institutions to deliver greater insight into children with rare and complex syndromes.

Midlands Mass Spectrometry Group (MMSG)
Midlands Mass Spectrometry Group

The MMSG was established by Midlands Innovation, and affiliated Midlands institutions, in order to coordinate knowledge transfer and equipment sharing among universities based within the region.

Medication Optimisation Research Group
Medication Optimisation Research Group

The group aims to translate research into practice. Membership is open to all with an interest in research into Medication Optimisation.